Save the Date: International Webinar
CDK4/6 Inhibition in Early and Advanced Breast Cancer
Recent Data and Controversies 2024
| Datum: | 30.10.2024 |
| Beginn/Ende: | 5.30 – 7.30 pm (CET) |
| Ort: | Online (Webinar) |
| Programm | Download PDF |
06.08.2024
We invite you to join our ABCSG webinar on the current status and future perspectives of CDK4/6 inhibitors in breast cancer treatment. This year’s session expands beyond early breast cancer and will also focus on the advanced setting.
The event will feature internationally renowned speakers such as Cristina Saura, Wolfgang Janni, and Nadia Harbeck, alongside ABCSG experts Christian Singer and Gabriel Rinnerthaler. They will present the latest findings and data on CDK4/6 inhibitors, covering their use in both the adjuvant setting and in metastatic HR+ breast cancer. Topics include standard care practices in the first and second lines of treatment, assessment of endocrine responsiveness, selection criteria for CDK inhibitors in early breast cancer, and interpretation of recent trial outcomes.
A panel discussion with ABCSG experts Marija Balic, Rupert Bartsch, and Georg Pfeiler along with our distinguished guest speakers will interpret the data and their clinical implications – ABCSG President Michael Gnant will moderate the webinar and lead the audience Q&A.
We encourage your participation in the discussions and Q&A sessions, offering a unique opportunity to engage with leading experts. Please register to secure your spot at this informative webinar.
We look forward to an engaging and informative event and your active participation!
This event has been approved with 2 continuing medical education credits from the Austrian Medical Chamber (“DFP-Punkte”).
Registration is now closed.
The webinar will be recorded and will soon be available as an on-demand video in the member area of the ABCSG website.
supported by
Teilen auf